Cerebrovascular biology and the various neural barriers: Challenges and future directions

Edward Neuwelt, N. Joan Abbott, Lester Drewes, Quentin R. Smith, Pierre O. Couraud, E. Antonio Chiocca, Kenneth L. Audus, Nigel H. Greig, Nancy Doolittle

Research output: Contribution to journalArticle

31 Citations (Scopus)

Abstract

DESPITE MAJOR ADVANCES in neuroscience, potential therapeutic options for the treatment of central nervous system diseases often cannot be optimized secondary to the presence of the blood-brain barrier (BBB). During the next decade of inquiry, it is crucial that basic science and clinical research that is focused on overcoming the BBB, to optimize delivery to the central nervous system, be identified and supported as a priority topic. For this reason, the third international Cerebrovascular Biology and Blood-Brain Barrier Conference was convened in March 1998 in Gleneden Beach, OR. This meeting brought together basic science and clinical researchers from around the world to analyze BBB function and to discuss delivery of effective agents to the central nervous system for treatment of brain disease. This report summarizes the information presented at the meeting and the discussions that ensued. The current state of knowledge, obstacles to further understanding the BBB, and research priorities are identified.

Original languageEnglish (US)
Pages (from-to)604-609
Number of pages6
JournalNeurosurgery
Volume44
Issue number3
StatePublished - Mar 1999

Fingerprint

Blood-Brain Barrier
Central Nervous System Agents
Central Nervous System Diseases
Brain Diseases
Neurosciences
Research
Central Nervous System
Research Personnel
Direction compound
Therapeutics

Keywords

  • Blood-brain barrier
  • Cerebrovascular biology
  • Neural barriers

ASJC Scopus subject areas

  • Clinical Neurology
  • Surgery

Cite this

Neuwelt, E., Abbott, N. J., Drewes, L., Smith, Q. R., Couraud, P. O., Chiocca, E. A., ... Doolittle, N. (1999). Cerebrovascular biology and the various neural barriers: Challenges and future directions. Neurosurgery, 44(3), 604-609.

Cerebrovascular biology and the various neural barriers : Challenges and future directions. / Neuwelt, Edward; Abbott, N. Joan; Drewes, Lester; Smith, Quentin R.; Couraud, Pierre O.; Chiocca, E. Antonio; Audus, Kenneth L.; Greig, Nigel H.; Doolittle, Nancy.

In: Neurosurgery, Vol. 44, No. 3, 03.1999, p. 604-609.

Research output: Contribution to journalArticle

Neuwelt, E, Abbott, NJ, Drewes, L, Smith, QR, Couraud, PO, Chiocca, EA, Audus, KL, Greig, NH & Doolittle, N 1999, 'Cerebrovascular biology and the various neural barriers: Challenges and future directions', Neurosurgery, vol. 44, no. 3, pp. 604-609.
Neuwelt E, Abbott NJ, Drewes L, Smith QR, Couraud PO, Chiocca EA et al. Cerebrovascular biology and the various neural barriers: Challenges and future directions. Neurosurgery. 1999 Mar;44(3):604-609.
Neuwelt, Edward ; Abbott, N. Joan ; Drewes, Lester ; Smith, Quentin R. ; Couraud, Pierre O. ; Chiocca, E. Antonio ; Audus, Kenneth L. ; Greig, Nigel H. ; Doolittle, Nancy. / Cerebrovascular biology and the various neural barriers : Challenges and future directions. In: Neurosurgery. 1999 ; Vol. 44, No. 3. pp. 604-609.
@article{231a4ff45bfc425e98e3b0f38bf89025,
title = "Cerebrovascular biology and the various neural barriers: Challenges and future directions",
abstract = "DESPITE MAJOR ADVANCES in neuroscience, potential therapeutic options for the treatment of central nervous system diseases often cannot be optimized secondary to the presence of the blood-brain barrier (BBB). During the next decade of inquiry, it is crucial that basic science and clinical research that is focused on overcoming the BBB, to optimize delivery to the central nervous system, be identified and supported as a priority topic. For this reason, the third international Cerebrovascular Biology and Blood-Brain Barrier Conference was convened in March 1998 in Gleneden Beach, OR. This meeting brought together basic science and clinical researchers from around the world to analyze BBB function and to discuss delivery of effective agents to the central nervous system for treatment of brain disease. This report summarizes the information presented at the meeting and the discussions that ensued. The current state of knowledge, obstacles to further understanding the BBB, and research priorities are identified.",
keywords = "Blood-brain barrier, Cerebrovascular biology, Neural barriers",
author = "Edward Neuwelt and Abbott, {N. Joan} and Lester Drewes and Smith, {Quentin R.} and Couraud, {Pierre O.} and Chiocca, {E. Antonio} and Audus, {Kenneth L.} and Greig, {Nigel H.} and Nancy Doolittle",
year = "1999",
month = "3",
language = "English (US)",
volume = "44",
pages = "604--609",
journal = "Neurosurgery",
issn = "0148-396X",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Cerebrovascular biology and the various neural barriers

T2 - Challenges and future directions

AU - Neuwelt, Edward

AU - Abbott, N. Joan

AU - Drewes, Lester

AU - Smith, Quentin R.

AU - Couraud, Pierre O.

AU - Chiocca, E. Antonio

AU - Audus, Kenneth L.

AU - Greig, Nigel H.

AU - Doolittle, Nancy

PY - 1999/3

Y1 - 1999/3

N2 - DESPITE MAJOR ADVANCES in neuroscience, potential therapeutic options for the treatment of central nervous system diseases often cannot be optimized secondary to the presence of the blood-brain barrier (BBB). During the next decade of inquiry, it is crucial that basic science and clinical research that is focused on overcoming the BBB, to optimize delivery to the central nervous system, be identified and supported as a priority topic. For this reason, the third international Cerebrovascular Biology and Blood-Brain Barrier Conference was convened in March 1998 in Gleneden Beach, OR. This meeting brought together basic science and clinical researchers from around the world to analyze BBB function and to discuss delivery of effective agents to the central nervous system for treatment of brain disease. This report summarizes the information presented at the meeting and the discussions that ensued. The current state of knowledge, obstacles to further understanding the BBB, and research priorities are identified.

AB - DESPITE MAJOR ADVANCES in neuroscience, potential therapeutic options for the treatment of central nervous system diseases often cannot be optimized secondary to the presence of the blood-brain barrier (BBB). During the next decade of inquiry, it is crucial that basic science and clinical research that is focused on overcoming the BBB, to optimize delivery to the central nervous system, be identified and supported as a priority topic. For this reason, the third international Cerebrovascular Biology and Blood-Brain Barrier Conference was convened in March 1998 in Gleneden Beach, OR. This meeting brought together basic science and clinical researchers from around the world to analyze BBB function and to discuss delivery of effective agents to the central nervous system for treatment of brain disease. This report summarizes the information presented at the meeting and the discussions that ensued. The current state of knowledge, obstacles to further understanding the BBB, and research priorities are identified.

KW - Blood-brain barrier

KW - Cerebrovascular biology

KW - Neural barriers

UR - http://www.scopus.com/inward/record.url?scp=0033049584&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033049584&partnerID=8YFLogxK

M3 - Article

C2 - 10069598

AN - SCOPUS:0033049584

VL - 44

SP - 604

EP - 609

JO - Neurosurgery

JF - Neurosurgery

SN - 0148-396X

IS - 3

ER -